Tailoring the therapy to the patient with mitral and tricuspid regurgitation to avoid adverse long-term outcomes. Tang GHL, Dangas GD. Catheter Cardiovasc Interv 2022;99:1857-1858.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang GHL, Dangas GD. Tailoring the therapy to the patient with mitral and tricuspid regurgitation to avoid adverse long-term outcomes. Catheter Cardiovasc Interv 2022;99:1857-1858.
PMID: 35568980